Abstract #0946

Novel magnetic resonance kidney biomarker Parenchyma-T2 for assessment of Autosomal dominant polycystic kidney disease

Florian Siedek¹, Franziska Grundmann², Kilian Weiss¹, Daniel Pinto dos Santos¹, Sita Arjune², Stefan Haneder¹, Thorsten Persigehl¹, Roman-Ulrich Mueller², and Bettina Baessler¹

¹Radiology, University of Cologne, Cologne, Germany, ²Department II of Internal Medicine, University of Cologne, Cologne, Germany

Novel biomarkers for a more sensitive and quick assessment of ADPKD patients especially in those cases where kidney function is still preserved and can be maintained is urgently needed. We analyzed in 139 patients and 10 healthy controls if magnetic resonance T2 mapping of the kidneys allows a sufficient differentiation of cyst fraction as a surrogate marker for disease severity. The new biomarker parenchyma-T2 showed the strongest correlation to renal cyst fraction and was faster to determine than the established biomarker htTKV. Consequently, parenchyma-T2 has the potential to serve as a novel predictive biomarker especially in early stages of disease.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.